Penumbra
PEN
#1739
Rank
C$17.66 B
Marketcap
C$449.10
Share price
-0.37%
Change (1 day)
28.62%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Cash on Hand

Cash on Hand as of March 2026 : C$0.87 Billion

According to Penumbra's latest financial reports the company has C$0.87 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Penumbra - Cash on Hand chart (from 2014 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31C$0.74 B52.87%
2024-12-31C$0.48 B27.25%
2023-12-31C$0.38 B50.33%
2022-12-31C$0.25 B-21.45%
2021-12-31C$0.32 B-3.81%
2020-12-31C$0.33 B36.52%
2019-12-31C$0.24 B-9.61%
2018-12-31C$0.27 B1.43%
2017-12-31C$0.26 B55.93%
2016-12-31C$0.17 B-16.18%
2015-12-31C$0.20 B245.1%
2014-12-31C$59.81 M310.87%
2013-12-31C$14.55 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Merit Medical
MMSI
C$0.69 B-20.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Inari Medical
NARI
C$0.15 B-81.88%๐Ÿ‡บ๐Ÿ‡ธ USA